Galectin Therapeutics

Norcross
37 Total Employees
View Website
Pharmaceutical
Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin’s lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.

Galectin Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site:
Norcross, Georgia, USA